Literature DB >> 6328728

Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.

R Burrows, D Goodridge, M S Denyer.   

Abstract

Vaccinated yearlings , two-year-old and in-foal pony mares with appropriate controls were exposed to aerosols of a subtype 1 virus one to two months after two or three vaccinations; all became infected. No obvious differences in the febrile responses, clinical signs and subsequent abortions were found between vaccinated and control mares. All vaccinated yearlings and two-year-old ponies developed a febrile respiratory disease but this was less severe than that suffered by the controls and the amounts and duration of virus shedding were reduced.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328728     DOI: 10.1136/vr.114.15.369

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  15 in total

1.  Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1alpha, 1beta, and 2 and tumor necrosis factor alpha.

Authors:  P M Smith; Y Zhang; W D Grafton; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection.

Authors:  C G Bridges; N Edington
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

4.  Characterization of an antigenic site on glycoprotein 13 (gC) of equid herpesvirus type-1.

Authors:  R Sinclair; B J Moult; J A Mumford
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse.

Authors:  S Charan; K Palmer; P Chester; A R Mire-Sluis; A Meager; N Edington
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

6.  Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.

Authors:  Alexandra Allkofer; Marie Garvey; Evelyn Ryan; Rachel Lyons; Megan Ryan; Gabija Lukaseviciute; Cathal Walsh; Monica Venner; Ann Cullinane
Journal:  Arch Virol       Date:  2021-01-07       Impact factor: 2.574

7.  Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.

Authors:  Patrick M Smith; Shannon M Kahan; Colin B Rorex; Jens von Einem; Nikolaus Osterrieder; Dennis J O'Callaghan
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1.

Authors:  D Tewari; J S Gibson; J D Slater; T O'Neill; D Hannant; G P Allen; H J Field
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

Authors:  P M Smith; Y Zhang; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice.

Authors:  T Bartels; F Steinbach; G Hahn; H Ludwig; K Borchers
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.